Po Box 6500
6401 JH Heerlen
The combination of Firmenich and DSM will establish the leading creation and innovation partner in nutrition, beauty and well-being with four high-performing and complementary businesses, each with pioneering, leadership positions:
- Perfumery & Beauty, with combined revenues of €3.3bn, will be the foremost creator of positive fragrances and beauty products and a global aroma ingredients business that together have leadership in renewable, natural, proprietary biodegradable and biotechnology-derived ingredients. Firmenich's leading global Perfumery and Ingredients business will expand into Beauty through the addition of DSM's Personal Care & Aroma business to delight consumers with superior sensorial experiences and differentiated performance, delivering active benefits, addressing clean & hygiene, health & reassurance and emotion & well-being
- Food & Beverage / Taste & Beyond, with combined revenues of €2.7bn, will form a global-scale partner to the food and beverage industry with extensive capabilities in taste, nutrition and functionality in order to provide delicious, nutritious and sustainable products that deliver unique and superior consumer experiences. The new business will lead the diet transformation in creating healthier, great-tasting, accessible food and beverages with more natural and sustainable ingredients, including market and innovation leadership in naturals and clean label products; in plant-based foods; and in supporting a superior taste experience whilst enhancing food's nutritional profile (for example with vitamins, probiotics, and lipids and reducing sugar and salt)
- Health, Nutrition & Care, with revenues of €2.2bn, will continue its development as an end-to-end partner providing customized quality solutions that support the health of people at every life stage. It will aim to keep the world's growing population healthy through a broad portfolio of sustainable, science-backed innovative solutions, addressing consumers' health and lifestyle needs, for customers in the dietary supplements, early-life nutrition, pharmaceuticals, medical nutrition, nutrition improvement for the under-nourished, and medical devices markets
- Animal Nutrition & Health, with revenues of €3.3bn, will continue to focus on specialty science- and technology-driven solutions to the ever-increasing demand for protein such as meat but also eggs, fish and dairy, while also alleviating the pressure on the planet's finite natural resources. The business is leading a robust and achievable transformation to make animal farming worldwide radically more sustainable by empowering farmers with essential products such as vitamins. It is one of the world's largest suppliers of eubiotics, enzymes, and mycotoxin risk management, as well as a wide range of impactful innovations such as methane inhibitor Bovaer® and fish-oil algae-alternative Veramaris®
The four businesses will be supported by a world-class foundation in science and technology, a vertically integrated portfolio of nutrition, natural and renewable ingredients, as well as best-in-class business functions. Both DSM and Firmenich have successful track records of delivering ground-breaking innovations that create and reshape markets for growth (for example Bovaer®, Veramaris®, biodegradable fragrance encapsulation, renewable fragrance materials, sugar and salt reduction, plant-based foods, fermentation processes for human milk oligosaccharides, and lipids). DSM-Firmenich will operate at the highest safety and quality standards, with strong regional manufacturing presence ensuring supply continuity, resilience and trust for our customers. DSM-Firmenich will continue the two companies' relentless commitment to sustainability across the value chain.
Present at parks
DSM and Firmenich to merge, becoming the leading creation and innovation partner in nutrition, beauty and well-being
The combination will bring together Firmenich’s unique leading Perfumery and Taste businesses, its world-class science platforms and associated co-creation capabilities with DSM’s outstanding Healt...
LANXESS to acquire DSM Elastomers
An agreement in principle involving the sale of DSM Elastomers to LANXESS for EUR 310 million on a cash and debt-free basis.
DSM plans new production site for Bovaer® in Dalry, Scotland
DSM is planning to realize large scale production capacity for its novel methane-reducing feed additive for ruminants, Bovaer® with a new 100 mil pound (€117 mln) plant at its existing site in Dalr...
DSM strengthens its market-leading position in high-performance specialty polymers
DSM announced the operational launch of a new production line for Arnitel® in Emmen, the Netherlands. The capacity will be expanded by 20% and will enable greater supply flexibility and security.
DSM significantly reduces CO2 emissions at vitamin production facility in Sisseln, Switzerland
DSM announced that it reduces CO2 emissions at its vitamin production facility in Sisseln, Switzerland, by 50,000 tons/year.
DSM expands its sustainable liquid polyester production capacity and other specialty resins in Meppen
This completed expansion follows the strong growth in our can and coil coatings segment in recent years, with growth driven by the market shift from epoxy-based packaging coatings toward new more s...
DSM to expand capacity of high performance plastics
Royal DSM announced it is in the process of expanding the capacity of its specialty polymers plants in Emmen and Geleen, the Netherlands. DSM is responding to strong customer demand in high tempera...
DSM invests €15 million to expand capacity at Coating Resins plant in Meppen (Germany)
The facility is specialized in the production of liquid polyesters and other specialty resins
DSM completes multi-million investment in Emmen: more jobs and environmental benefits
Modernization of DSM Engineering Plastics production facilities in Emmen is bearing fruit. The facilities use waste water from the production plant to reduce emissions into the air of volatile orga...
DSM and Roquette to open commercial scale bio-based succinic acid plant in 2012
build a commercial scale plant for the production of bio-based succinic acid, the first non-fossil feedstock derived chemical building block that allows customers in the chemical industry to choose...
DSM inaugurates new resins plant in Germany
The new plant was built at the existing site of DSM NeoResins+ in Meppen. The plant allows for further expansions in the future. With the new plant DSM NeoResins+ reinforces its strong position in ...
Appointment New CEO and Capacity Expansion Diolen Industrial Fibers
Retirement of Mr. Jan Michiels as CEO and General Manager of Diolen Industrial Fibers. Appointment of Mr. Eric Tierie as CEO and General Manager of Diolen Industrial Fibers. Appointment of Mr. Wout...
DSM invests in de-bottlenecking of acrylonitrile plant to increase capacity by 10%
The project will lead to a capacity increase of 24,000 tons per year, which means over 10% of the existing capacity of 235,000 tons per year. The investment will be around EUR 15 million. The proje...
DSM Opens The World's Largest Vitamin E Plant In Sisseln, Switzerland
The new factory has the capacity to produce approximately 25 000 tons of vitamin E a year.